Posted inBiotechnology
AstraZeneca returns to China’s CSPC for $18.5B obesity deal
The ink was barely dry on AstraZeneca’s announcement of a landmark investment in its Chinese capabilities before the U.K.-based pharma…
Posted inBiotechnology
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Moderna has out-licensed a rare disease drug candidate to Recordati, accepting $50 million upfront for an asset that could deliver registrational…
Posted inGenetics
DNA-Protein Crosslinks Drive Inflammation Linked to Early Aging
Data from a new study in mice connects unrepaired DNA-protein crosslinks (DPCs), highly toxic tangles of protein and DNA, to…
Posted inBiotechnology
Giant Hornet Genomes Unraveled by Centromere Expansions
In a groundbreaking study that sheds light on the genomic architecture of the giant hornet, researchers have unveiled the intricate…
Posted inBiotechnology
Oxygen-Responsive Platinum(II) Porphyrin for Hypoxia Imaging
Recent advancements in biomedical research have unveiled groundbreaking technologies that may revolutionize the diagnosis and treatment of a range of…
Posted inBiotechnology
Red Blood Cell Deformation Under Extreme Strain Rates
In a groundbreaking study, researchers have taken significant steps toward understanding the mechanics of red blood cells under extreme physiological…
Posted inBiotechnology
Optimizing Hybrid Powertrains with Real-Time Route Data
In an era where hybrid vehicles are becoming increasingly popular, a groundbreaking study led by Riegelbeck, C., Vadamalu, R.S., and…
Posted inBiotechnology
Colorectal Cancer: EVs Drive Immune Evasion and Therapy
In the realm of colorectal cancer research, a groundbreaking study has emerged, shedding light on the intricate role of extracellular…
Posted inGenetics
Hippocampal Replay Persists but Loses Structure in Alzheimer’s Model
Credit: Westend61/Getty Images Place cells—the hippocampal neurons discovered by Nobel laureate John O’Keefe, PhD—normally fire in crisp, rapid sequences that…
Posted inGenetics
Immunotherapy Reduces Plaque in Mouse Arteries, Suggesting Coronary Disease Intervention
Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against…